MARIN BROUCEK: Open Payments
NPI 1588942262 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 18 payments from 7 companies in 2025. Trend: 2023 $29 · 2024 $123 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $141 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: ARISTADA, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, VIVITROL, UZEDY, VRAYLAR, Auvelity.
Industry payments across NE — which companies pay providers there.
